Citation Impact
Citing Papers
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
1996
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
1998
A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment
1995 Standout
Cushing's syndrome
2015 Standout
Synthesis and biological activity of analogues of diazaquinomycin A, a new thymidylate synthase inhibitor.
1989 StandoutNobel
Treatment of neuroendocrine tumors
1994
Metastatic medullary thyroid carcinoma: Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil
1988
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Neuroendocrine gastrointestinal tumours
1996
Carcinoid A Comprehensive Review
2003
Recent Advances in the Treatment of Breast Cancer
1991
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Treatment of medullary thyroid carcinoma: an update.
2001
Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system
1988 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
An analysis of 8305 cases of carcinoid tumors
2000 Standout
Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors – A Retrospective Single-Center Analysis
2003
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors a prospective phase II study in 24 patients
1993
Clinical Pharmacology of 5-Fluorouracil
1989 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Carcinoid Tumors
1999
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
6 Recent Progress in the Medicinal Chemistry of 2,4-Diaminopyrimidines
1982
Influence of protease inhibitors and energy metabolism on intracellular protein breakdown in starving Escherichia coli
1973 StandoutNobel
Breast Cancer Statistics, 2022
2022 Standout
Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance
1980
Diazaquinomycin A, a new antifolate antibiotic, inhibits thymidylate synthase.
1985 StandoutNobel
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Therapeutic Alternatives in Metastatic Neuroendocrine Tumors
1998
Angiodysgenetische nekrotisierende Myelopathie
1968
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
1981
Carcinoid Tumors of the Gut
1997
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
2006
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
Phase II Study of Recombinant Human Endostatin in Patients With Advanced Neuroendocrine Tumors
2006
Effects of Protease Inhibitors on Protein Breakdown in Escherichia coli
1972
Thyroid carcinoma
2003 Standout
5-fluorouracil and methotrexate combination chemotherapy: The effect of drug scheduling
1981
Works of E Fölsch being referenced
Inactivation by Mouse Serum of a Tightly Bound Inhibitor of Dihydrofolate Reductase
1970
Fluoropyrimidine-induced antagonism to free and tightly bound methotrexate: Suppression of [14C] formate incorporation into RNA and protein
1980
Carcinoids: The association of histologic growth pattern and survival
1983
[Angiodysgenetic myelomalacia; Foix-Alajouanine disease].
1958
Treatment of metastatic breast cancer with aminoglutethimide
1981
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
1984
DISCUSSION PAPER: STUDIES WITH A 2,4‐DIAMINO‐5‐CHLORO‐QUINAZOLINE ANTIFOLATE: IN VITRO AND IN VIVO CORRELATES IN NORMAL AND LYMPHOSARCOMA DOGS
1971